Cemal Bilaç
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cemal Bilaç has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Aylin Türel Ermertcan
Department of Dermatology and Venereology Manisa Celal Bayar University Manisa Turkey
4 shared publications - Peyker Temiz
Celal Bayar Univ, Dept Pathol, Fac Med, Manisa, Turkey
2 shared publications Beyhan Özyurt
Department of Public Health, Faculty of Medicine Manisa Celal Bayar University Manisa Turkey
1 shared publication- Can Tercan
Department of Obstetrics and Gynecology, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey
1 shared publication Ece Gökyayla
Manisa Celal Bayar University, Faculty of Medicine, Department of Dermatology, Manisa, Turkey
1 shared publication- Ergün Tercan
Manisa Merkezefendi State Hospital, Clinic of Pathology, Manisa, Türkiye
1 shared publication
Latest Publications
- 16 November 2026
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- p. 1-9
Unlocking the secrets of psoriasis treatment: exploring the impact of blood ratios on treatment success
- 16 November 2026
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- p. 1-9
Unlocking the secrets of psoriasis treatment: exploring the impact of blood ratios on treatment success
- Open Access
- 6 August 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (5)
Dermoscopic features of cutaneous endometriosis arising in a caesarean section
- 6 August 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (5)
Open AccessDermoscopic features of cutaneous endometriosis arising in a caesarean section
- 29 July 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e14094
Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer
Background Skin cancers are the most common type of cancer. Nonmelanoma skin cancers (NMSC) are more common than melanoma. Although the mortality rate is low, cancer word can be frightening for patients. Surgery is the main treatment. As skin cancers are most commonly located on the face, undesirable cosmetic results can occur as a result of treatments or due to primary disease. Therefore the quality of life of patients could be affected. Aims To determine the effect of surgical treatment on quality of life of the patients with facial NMSC using Dermatology Life Quality Index (DLQI) at baseline and 3 months after surgery. We aimed to see if there was any improvement in quality of life scores after surgery, and to identify factors affecting quality of life. Methods A total of 255 patients; 174 basal cell carcinoma (BCC) (68.2%) and 81 squamous cell carcinoma (SCC) (31.8%) were included in our study. All participants completed DLQI at baseline and 3 months after surgery. Results The mean total DLQI scores were 6.37±6.28 in patients with BCC, and 6.35±6.16 in patients with SCC. The mean total DLQI scores were 3.96±5.14 in patients with BCC (p<0.001), and 4.49±5.24 in patients with SCC (p<0.001) 3 months after surgery. In patients with primary skin cancer, all subscale scores and total DLQI scores were worse than the recurrent skin cancer group in both BCC and SCC at baseline. According to the treatment modalities, total DLQI scores and all subscales were worse in the graft group in BCC and SCC patients at baseline. Interestingly, the sex and the type of skin cancer did not affect quality of life, but tumor localization [(Auricula OR: 6.45 (95% CI: 1.28‐37.47) and eyelid OR:0.20 (95% CI: 0.04‐0.96)] treatment procedure [(Flap procedure OR: 7.90 (95% CI: 2.64‐23.62) and graft procedure OR: 5.47 (95% CI: 1.60‐18.71)] and, primary tumor OR:3.86 (95% CI: 1.01‐14.78) were significant. Conclusion The quality of life of skin cancer patients was affected by tumor localization, treatment procedure, primary or recurrent tumor. The quality of life showed a significant improvement in patients with facial NMSC after surgical treatment. However, the type of NMSC seems to have no effect on quality of life.
- 29 July 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e14094
Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer
Background Skin cancers are the most common type of cancer. Nonmelanoma skin cancers (NMSC) are more common than melanoma. Although the mortality rate is low, cancer word can be frightening for patients. Surgery is the main treatment. As skin cancers are most commonly located on the face, undesirable cosmetic results can occur as a result of treatments or due to primary disease. Therefore the quality of life of patients could be affected. Aims To determine the effect of surgical treatment on quality of life of the patients with facial NMSC using Dermatology Life Quality Index (DLQI) at baseline and 3 months after surgery. We aimed to see if there was any improvement in quality of life scores after surgery, and to identify factors affecting quality of life. Methods A total of 255 patients; 174 basal cell carcinoma (BCC) (68.2%) and 81 squamous cell carcinoma (SCC) (31.8%) were included in our study. All participants completed DLQI at baseline and 3 months after surgery. Results The mean total DLQI scores were 6.37±6.28 in patients with BCC, and 6.35±6.16 in patients with SCC. The mean total DLQI scores were 3.96±5.14 in patients with BCC (p<0.001), and 4.49±5.24 in patients with SCC (p<0.001) 3 months after surgery. In patients with primary skin cancer, all subscale scores and total DLQI scores were worse than the recurrent skin cancer group in both BCC and SCC at baseline. According to the treatment modalities, total DLQI scores and all subscales were worse in the graft group in BCC and SCC patients at baseline. Interestingly, the sex and the type of skin cancer did not affect quality of life, but tumor localization [(Auricula OR: 6.45 (95% CI: 1.28‐37.47) and eyelid OR:0.20 (95% CI: 0.04‐0.96)] treatment procedure [(Flap procedure OR: 7.90 (95% CI: 2.64‐23.62) and graft procedure OR: 5.47 (95% CI: 1.60‐18.71)] and, primary tumor OR:3.86 (95% CI: 1.01‐14.78) were significant. Conclusion The quality of life of skin cancer patients was affected by tumor localization, treatment procedure, primary or recurrent tumor. The quality of life showed a significant improvement in patients with facial NMSC after surgical treatment. However, the type of NMSC seems to have no effect on quality of life.
- 31 May 2020
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (4)
Functional medicine with dermatology insite: A systematic approach for diagnosis and treatment of chronic diseases
Click on the article title to read more.
- 31 May 2020
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (4)
Functional medicine with dermatology insite: A systematic approach for diagnosis and treatment of chronic diseases
Click on the article title to read more.
- 3 November 2009
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 29 (1) , 67-69
Acute generalized exanthematous pustulosis with lymphangitis triggered by a spider bite
Acute generalized exanthematous pustulosis (AGEP) is a rare, severe cutaneous reaction pattern that, in the majority (>90%) of cases, is related to administration of medication. It can be seen in both genders and in all ages. The cutaneous manifestations of AGEP are usually seen 1–14 days after drug administration. A 39-year-old woman presented to our outpatient clinic with the complaint of generalized erythema, burning, and rash. She explained that 2 days before presentation a spider bite had occurred on her left forearm, after which she had experienced pain and erythema spreading gradually to the left upper extremity. On her dermatologic examination, she had an indurated necrotic plaque on the left forearm, which had an upward-spreading linear erythema. Additionally, she had diffuse erythema on her body and small pustules over erythematous skin, especially located on the left popliteal fossa and gluteal region. Based on the clinical and histopathologic findings, she was diagnosed as having AGEP. Because there was no drug use in her history, we attributed her AGEP lesions to the spider bite. This case is interesting, because the patient also had lymphangitis. Herein, we present the fifth case reported in the literature of AGEP caused by a spider bite.
- 3 November 2009
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 29 (1) , 67-69
Acute generalized exanthematous pustulosis with lymphangitis triggered by a spider bite
Acute generalized exanthematous pustulosis (AGEP) is a rare, severe cutaneous reaction pattern that, in the majority (>90%) of cases, is related to administration of medication. It can be seen in both genders and in all ages. The cutaneous manifestations of AGEP are usually seen 1–14 days after drug administration. A 39-year-old woman presented to our outpatient clinic with the complaint of generalized erythema, burning, and rash. She explained that 2 days before presentation a spider bite had occurred on her left forearm, after which she had experienced pain and erythema spreading gradually to the left upper extremity. On her dermatologic examination, she had an indurated necrotic plaque on the left forearm, which had an upward-spreading linear erythema. Additionally, she had diffuse erythema on her body and small pustules over erythematous skin, especially located on the left popliteal fossa and gluteal region. Based on the clinical and histopathologic findings, she was diagnosed as having AGEP. Because there was no drug use in her history, we attributed her AGEP lesions to the spider bite. This case is interesting, because the patient also had lymphangitis. Herein, we present the fifth case reported in the literature of AGEP caused by a spider bite.